Aimmune Therap (AIMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Operating Expenses | 249,804 | 215,341 | 133,274 | 81,527 | 35,997 |
| Operating Income | -249,804 | -215,341 | -133,274 | -81,527 | -35,997 |
| Interest Expense | 4,916 | 113 | 114 | 0 | 0 |
| Other Income | 6,939 | 4,763 | 2,119 | 703 | 181 |
| Pre-tax Income | -247,781 | -210,691 | -131,269 | -80,824 | -35,816 |
| Income Tax | 716 | 61 | 56 | N/A | N/A |
| Net Income Continuous | -248,497 | -210,752 | -131,325 | -80,824 | -35,816 |
| Net Income | $-248,497 | $-210,752 | $-131,325 | $-80,824 | $-35,816 |
| EPS Basic Total Ops | -3.97 | -3.67 | -2.61 | -1.89 | -1.88 |
| EPS Basic Continuous Ops | -3.97 | -3.67 | -2.61 | -1.89 | -1.88 |
| EPS Diluted Total Ops | -3.97 | -3.67 | -2.61 | -1.89 | -1.88 |
| EPS Diluted Continuous Ops | -3.97 | -3.67 | -2.61 | -1.89 | -1.88 |
| EPS Diluted Before Non-Recurring Items | -3.97 | -3.67 | -2.61 | -1.89 | -1.88 |
| EBITDA(a) | $-247,349 | $-214,629 | $-131,797 | $-80,074 | $-35,558 |